RAFAEL HOLDINGS, INC. Business Acquisition, Pro Forma Revenue
RAFAEL HOLDINGS, INC. (RFL) reported Business Acquisition, Pro Forma Revenue of $758.00 thousand for the 6-month period ending 2026-01-31, per its 10-Q filed 2026-03-16.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2025-07-31 was $816.00K, a 183.33% increase year-over-year.
- RAFAEL HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2025-04-30 was $472.00K, a 12.27% decline year-over-year.
- RAFAEL HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2025-01-31 was $397.00K.
- RAFAEL HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2024-10-31 was $362.00K, a 432.35% increase year-over-year.
- RAFAEL HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2025 was $2.05M, a 15.66% increase from fiscal 2024.
- RAFAEL HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2024 was $1.77M, a 534.05% increase from fiscal 2023.
- RAFAEL HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2023 was $279.00K.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 3 month as first filed | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 9 month as first filed | Business Acquisition, Pro Forma Revenue 12 month | Business Acquisition, Pro Forma Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-01-31 | $758.00K 10-Q · filed 2026-03-16 | ||||||
| 2025-07-31 | $816.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $1.29M derived: sum of 2 quarters · filed 2026-06-11 | $1.69M derived: sum of 3 quarters · filed 2026-06-11 | $2.05M 10-K · filed 2025-10-29 | |||
| 2025-04-30 | $472.00K 10-Q · filed 2026-06-11 | $869.00K derived: sum of 2 quarters · filed 2026-06-11 | $1.23M 10-Q · filed 2026-06-11 | $1.52M derived: sum of 4 quarters · filed 2026-06-11 | |||
| 2025-01-31 | $397.00K 10-Q · filed 2026-03-16 | $759.00K derived: sum of 2 quarters · filed 2026-03-16 | $1.05M derived: sum of 3 quarters · filed 2026-03-16 | $1.58M derived: sum of 4 quarters · filed 2026-03-16 | |||
| 2024-10-31 | $362.00K 10-Q · filed 2025-12-12 | $650.00K derived: sum of 2 quarters · filed 2025-12-12 | $1.19M derived: sum of 3 quarters · filed 2025-12-12 | ||||
| 2024-07-31 | $288.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $826.00K derived: sum of 2 quarters · filed 2025-10-29 | $1.77M 10-K · filed 2025-10-29 | $637.00K 10-K · filed 2024-11-07 | |||
| 2024-04-30 | $538.00K 10-Q · filed 2025-06-11 | $337.00K 10-Q · filed 2024-06-14 | $1.48M 10-Q · filed 2025-06-11 | $472.00K 10-Q · filed 2024-06-14 | |||
| 2023-10-31 | $68.00K 10-Q · filed 2024-12-11 | $136.00K derived: sum of 2 quarters · filed 2024-12-20 | $207.00K derived: sum of 3 quarters · filed 2024-12-20 | ||||
| 2023-07-31 | $68.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-20 | $139.00K derived: sum of 2 quarters · filed 2024-12-20 | $279.00K 10-K/A · filed 2024-12-20 | ||||
| 2023-04-30 | $71.00K 10-Q · filed 2024-06-14 | $211.00K 10-Q · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |